|
14/01/2025
|
07:00
|
Diaceutics Opens US Headquarters
|
RNS
|
|
08/01/2025
|
07:00
|
New Service Launched & First Contract Signed
|
RNS
|
|
03/01/2025
|
15:39
|
PDMR Dealings & Total Voting Rights
|
RNS
|
|
19/12/2024
|
08:09
|
Holding(s) in Company
|
RNS
|
|
17/12/2024
|
10:46
|
Holding(s) in Company
|
RNS
|
|
17/12/2024
|
07:00
|
Diaceutics Wins New $5.1m Contract
|
RNS
|
|
10/12/2024
|
15:14
|
Holding(s) in Company
|
RNS
|
|
05/12/2024
|
07:00
|
Awarded UK Research Institute Grant Funding of £1m
|
RNS
|
|
03/12/2024
|
14:24
|
Total Voting Rights
|
RNS
|
|
28/11/2024
|
07:00
|
Expansion of US Commercial Activities
|
RNS
|
|
05/11/2024
|
07:00
|
Capital Markets Webinar
|
RNS
|
|
04/11/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
30/10/2024
|
14:58
|
PDMR Shareholding/Share Incentive Plan
|
RNS
|
|
29/10/2024
|
10:27
|
Board Change Update
|
RNS
|
|
25/10/2024
|
07:00
|
Issue of Share Options/PDMR Shareholdings
|
RNS
|
|
24/10/2024
|
12:53
|
Cancellation of Share Premium Account
|
RNS
|
|
07/10/2024
|
13:19
|
Holding(s) in Company
|
RNS
|
|
07/10/2024
|
07:00
|
Block Listing Return
|
RNS
|
|
02/10/2024
|
07:00
|
PDMR Shareholding/Share Incentive Plan
|
RNS
|
|
01/10/2024
|
07:00
|
Board Changes
|
RNS
|
|
17/09/2024
|
07:00
|
H1 2024 Results - Continued Performance & Growth
|
RNS
|
|
09/09/2024
|
07:00
|
Notice of Results & Presentations
|
RNS
|
|
02/09/2024
|
07:00
|
Appointment of Nominated Adviser and Broker
|
RNS
|
|
30/08/2024
|
15:45
|
PDMR Shareholding/Share Incentive Plan
|
RNS
|
|
27/08/2024
|
07:00
|
Diaceutics Launches Enhanced Rare-Disease Offering
|
RNS
|
|
19/08/2024
|
07:00
|
Enterprise Partnership and Launch of PMx
|
RNS
|
|
05/08/2024
|
07:00
|
Presenting at Canaccord Genuity Growth Conference
|
RNS
|
|
29/07/2024
|
18:09
|
PDMR Shareholding/SIP and TVR
|
RNS
|
|
29/07/2024
|
07:00
|
Issue of Share Options/PDMR Shareholdings
|
RNS
|
|
23/07/2024
|
07:05
|
Board Changes
|
RNS
|
|
23/07/2024
|
07:00
|
Revenue growth of 24% in H1 with 55% now recurring
|
RNS
|
|
11/07/2024
|
07:00
|
Senior Management Appointments
|
RNS
|
|
01/07/2024
|
07:00
|
PDMR Shareholding/SIP and Total Voting Rights
|
RNS
|
|
24/06/2024
|
13:15
|
Result of AGM
|
RNS
|
|
06/06/2024
|
07:00
|
Diaceutics - Capital Markets Event
|
RNS
|
|
29/05/2024
|
08:00
|
Notice of AGM and Posting of Annual Report
|
RNS
|
|
28/05/2024
|
07:00
|
Data to be Presented at 2024 ASCO Annual Meeting
|
RNS
|
|
24/05/2024
|
15:01
|
PDMR Shareholding/SIP and Total Voting Rights
|
RNS
|
|
23/05/2024
|
07:00
|
Director / PDMR Shareholding
|
RNS
|
|
21/05/2024
|
07:00
|
Revenue growth of 22% & order book growth of 57%
|
RNS
|
|
16/05/2024
|
07:00
|
Two New Enterprise-Wide Engagements
|
RNS
|
|
14/05/2024
|
07:00
|
Diaceutics - Capital Markets Event
|
RNS
|
|
01/05/2024
|
07:00
|
Notice of Results & Presentations
|
RNS
|
|
30/04/2024
|
07:00
|
PDMR Shareholding/SIP and TVR
|
RNS
|
|
09/04/2024
|
07:00
|
Appointment of Amie Mc Neice as VP of Marketing
|
RNS
|
|
05/04/2024
|
13:40
|
Block Listing Return
|
RNS
|
|
03/04/2024
|
07:00
|
PDMR Shareholding/Share Incentive Plan
|
RNS
|
|
02/04/2024
|
07:00
|
Director/PDMR/PCA Shareholding & TR1
|
RNS
|
|
07/03/2024
|
07:00
|
Director/PDMR Shareholding
|
RNS
|
|
01/03/2024
|
09:00
|
PDMR Shareholding / SIP and TVR
|
RNS
|